Depression Raises Risk of Death for Heart Attack Victims for Years After Attack

Only about 25 to 30% of these patients receive antidepressant drugs, treatment

By Jim Dryden

March 3, 2008 -- Depressed heart attack patients have a higher risk for sudden death in the months following a heart attack. Now a team led by researchers from Washington University School of Medicine in St. Louis has found that the risk continues for many years.

"There's a two- to four-fold increase in a person's risk of dying following a heart attack if they also happen to be depressed," says Robert. M. Carney, Ph.D., lead author of the new study and professor of psychiatry at Washington University.

	Related Stories
	Senior Citizen Men Get Depressed from Low Free Testosterone Level Testosterone supplement may contribute to successful treatment March 3, 2008 Depression is a Killer for Heart Attack Victims, Study Finds 'There is a whole series of factors that link depression and heart disease' Dec. 8, 2007 Large Study Proves Antidepressants Lower Suicide Risk for All Adults National Institute of Mental Health funds study of 226,866 patients July 6, 2007 Elderly Patients Not Responding to Depression Therapy Improve with Second Drug 84% of depressed elderly have problems in initial treatment June 1, 2007 Senior Citizens and Depression is Latest on NIHSeniorHealth National Institute on Aging, National Library of Medicine work together to produce special senior-friendly Website January 16, 2007 Dementia in Older Men Associated with High Levels of Female Hormone High estrogen may be consequence of, or early AD sign, rather than cause July 24, 2006 Read the latest news on Alzheimer's, Dementia & Mental Health

"Previously we thought the impact of depression was strongest for the first three to six months following a heart attack and then gradually dropped off within a couple of years. Instead, we found that the effect lasts for at least five years."

Carney, with colleagues from Duke University Medical Center, Harvard University, Yale University, the National Heart, Lung and Blood Institute (NIH) and the Mayo Clinic, followed more than 750 heart attack patients for five years. The findings will appear in an upcoming issue of the Journal of Affective Disorders and are currently available online.

Patients followed in the study had participated in the NIH-funded project Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD). A little less than half were diagnosed with depression.

In the five years following a heart attack, 106 patients died. Of those, 62 had been diagnosed with depression, while 44 had not. In gauging the effects of depression, the investigators also considered other risks including age, smoking, hypertension, gender and diabetes.

Some of those factors, like younger age and female gender, lower mortality risk. Smoking and diabetes tend to raise the risk of dying. Carney says his team used statistical methods to evaluate the ways in which the various factors influenced mortality risk. Then they removed the influence of all other factors from the risk equation in order to consider the statistical impact of depression itself.

"We found that after adjusting for those risk factors, depression continues to play a statistically significant role," he says.

One possible explanation for depression's lingering influence on mortality is its recurring nature. Because the disorder can come and go over many years, it also may continue to increase the risk of death for many years.

"People typically are depressed for a while, then they'll either get better with treatment or it may subside on its own," Carney says.

"But depression can always recur, and we think that because it is a recurring problem, whatever depression is doing to mortality risk after a heart attack, it continues doing for quite a long time."

Past studies have differed over how much depression affects survival following a heart attack. But Carney believes these new findings are more reliable because all of the patients in this study were personally interviewed to determine their depression status, whereas other studies have relied on self-reporting.

"In our experience, self-reporting tends to overestimate the risk because it's often not possible to evaluate the causes of various symptoms on self-report questionnaires," he explains.

"Say somebody reports having sleeping problems — that would go into the depression column as a symptom. But it's possible they are sleeping poorly because of a bad back or because they have to get up and go to the bathroom frequently during the night. During an interview, we can determine whether an individual symptom is related to depression or can be explained in some other way."

Carney's team also found that any clinically relevant depression increases the risk of death in heart attack patients. The risk was elevated both for patients with major depression, which requires the presence of five or more symptoms, and minor depression, which requires between two and four symptoms for diagnosis.

Major depression was associated with higher risk, but minor depression also was associated with a significant increase in mortality risk.

Even with mounting evidence of a link between depression and death in heart attack patients, only about 25 to 30 percent of these patients receive antidepressant drugs or other depression treatments.

That doesn't surprise Carney. His team reported in 2003 in the Journal of the American Medical Association that providing treatment for depression seemed to have little effect on whether patients survived or had a second heart attack. This could be because the treatments don't work for all patients, Carney says, and he suggests if current depression treatments could be improved, survival rates might increase, too.

To this end, his team is studying whether omega-3 fatty acids — the fatty acids found in fish oil — might improve antidepressant therapies in heart patients. They're giving an antidepressant drug and a special formulation of omega-3 to some heart patients and comparing them to depressed heart patients who receive an antidepressant but no omega-3.

"We have not been satisfied with the effectiveness of standard antidepressants at alleviating depression in this population of patients," Carney says. "We're studying omega-3, because there's preliminary evidence that the fatty acids also might make depression therapies more effective, both in treating depression and in improving heart health."

The new study is enrolling people with depression who have suffered a heart attack at least three months previously. After being evaluated for depression, patients will take an antidepressant and be randomly assigned to take a capsule containing either omega-3 or corn oil for 12 weeks. Carney's team evaluates both mood and heart function during the course of the study.

All medication, supplements, medical and psychiatric evaluations are provided free of charge. For more information about the study, call Cathi at (314) 286-1517 or Carol at (314) 286-1315.

Editor’s Notes:

Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, Berkman LF, Watkins LL, Czajkowski SM, Burg MM, Jaffe AS. Depression and five-year survival following acute myocardial infarction: a prospective study. Journal of Affective Disorders, 2008. doi:10.1016/j.jad.2007.12.005

This study was supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, and from the Lewis and Jean Sachs Charitable Lead Trust, St. Louis, MO

This ENRICHD study was supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Pfizer Inc. provided setraline (Zoloft) for that study.

Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's Hospitals. The School of Medicine is one of the leading medical research, teaching, and patient care institutions in the nation, currently ranked fourth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's Hospitals, the School of Medicine is linked to BJC HealthCare.